COMP <GO>
BGLC vs ACON // PIOTROSKI F-SCORE QUALITY
BioNexus Gene Lab Corp (NASDAQ) VS. Aclarion Inc. (NASDAQ) • 15-METRIC TALLY: BGLC 4
— ACON 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: ACON
LAST: $0.98 (-7.79%) • MKT CAP: $2.9M
piotroski-score
2/9
LAST: $1.97 (-3.43%) • MKT CAP: $5.7M
piotroski-score
3/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BGLC VS. ACON)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BGLC | ACON | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.60% | 9.00% | +5.60 | BGLC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -39.90% | -60.00% | +20.10 | BGLC | /operating-margins <GO> |
| Net Profit Margin | -40.20% | -60.00% | +19.80 | BGLC | /net-margins <GO> |
| Revenue Growth (YoY) | -21.90% | 65.60% | -87.50 | ACON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 0.20 | +1.92 | BGLC | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 2/9 | 3/9 | -1.00 | ACON | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 24.5 | 39.0 | -14.50 | ACON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.9M | $5.7M | -$2.8M | ACON | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BGLC REV | ACON REV | BGLC GROSS % | ACON GROSS % | BGLC FCF | ACON FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.4M | $75.7K | 14.6% | 9.0% | -$1.9M | -$7.2M |
| FY 2024 | $9.5M | $45.7K | 13.6% | -50.0% | -$2.3M | -$5.3M |
| FY 2023 | $9.8M | $75.4K | — | — | -$1.8M | -$3.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BGLC // BETA —
ACON // BETA —